Schubert & CO Organon & Co. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$21.42 - $32.08 $21 - $32	1 Added 0.52%	194 $4,000
Q4 2022 Jan 31, 2023	SELL	$23.31 - $28.61 $932 - $1,144	-40 Reduced 17.17%	193 $5,000
Q3 2022 Oct 21, 2022	SELL	$23.4 - $34.25 $351 - $513	-15 Reduced 6.05%	233 $5,000
Q2 2022 Aug 01, 2022	BUY	$31.66 - $38.9 $1,203 - $1,478	38 Added 18.1%	248 $8,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $2,984 - $3,857	-98 Reduced 31.82%	210 $7,000
Q4 2021 Jan 28, 2022	BUY	$28.67 - $37.13 $8,830 - $11,436	308 New	308 $9,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.